Published in Neuroepidemiology on September 24, 2007
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement (2008) 1.05
Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! Eur J Clin Pharmacol (2013) 0.94
Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting. Neuropsychiatr Dis Treat (2011) 0.81
Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease. Alzheimers Res Ther (2011) 0.77
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. J Neurol (2013) 0.77
Retirement age and the age of onset of Alzheimer's disease: results from the ICTUS study. PLoS One (2015) 0.75
kmlShape: An Efficient Method to Cluster Longitudinal Data (Time-Series) According to Their Shapes. PLoS One (2016) 0.75
Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials. Eur J Health Econ (2014) 0.75
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98
ESPEN guidelines for nutrition screening 2002. Clin Nutr (2003) 5.22
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet (1998) 4.89
Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc (2000) 3.59
Description of 1,108 older patients referred by their physician to the "Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability" at the gerontopole. J Nutr Health Aging (2014) 3.37
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology (2001) 2.78
The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study. Rheumatology (Oxford) (2003) 2.69
Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev (1996) 2.58
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging (2008) 2.54
The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging (2008) 2.53
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry (2006) 2.48
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging (2013) 2.44
Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci (2001) 2.43
Increased risk of mortality associated with social isolation in older men: only when feeling lonely? Results from the Amsterdam Study of the Elderly (AMSTEL). Psychol Med (2011) 2.42
Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet J (1993) 2.27
Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc (1993) 2.02
Androgen treatment of abdominally obese men. Obes Res (1993) 1.99
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism (1997) 1.97
Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ (2008) 1.88
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry (2009) 1.86
Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging (2009) 1.85
A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry (2005) 1.79
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil. Curr Med Res Opin (2002) 1.78
Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75
The primary care physician and Alzheimer's disease: an international position paper. J Nutr Health Aging (2010) 1.68
Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology (2004) 1.65
Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial. Age Ageing (2000) 1.63
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiol Aging (2010) 1.63
Economic consequences of the progression of rheumatoid arthritis in Sweden. Arthritis Rheum (1999) 1.61
The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Int J Geriatr Psychiatry (2010) 1.61
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord (1992) 1.61
MRI-based automated computer classification of probable AD versus normal controls. IEEE Trans Med Imaging (2008) 1.58
Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage (2010) 1.57
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects. Age Ageing (1994) 1.56
Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med (2013) 1.52
Depressive symptoms of Alzheimer caregivers are mainly due to personal rather than patient factors. Int J Geriatr Psychiatry (1998) 1.51
Determinants of cholesterol goal attainment at 12 months in patients with hypercholesterolaemia not at consensus goal after 3 months of treatment with lipid-lowering drugs. Int J Clin Pract (2007) 1.50
Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients. J Am Geriatr Soc (1996) 1.48
Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study). J Gerontol A Biol Sci Med Sci (2001) 1.47
[Risk factors management in 5708 ambulatory patients suffering from peripheral vascular disease followed in urban practices]. Arch Mal Coeur Vaiss (2005) 1.45
Identification and purification of the specific antigen of Paracoccidioides brasiliensis responsible for immunoelectrophoretic band E. Sabouraudia (1977) 1.44
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
Isolation of a specific antigen with alkaline phosphatase activity from soluble extracts of Paracoccidioides brasiliensis. Sabouraudia (1976) 1.41
Health and nutritional promotion program for patients with dementia (NutriAlz Study): design and baseline data. J Nutr Health Aging (2009) 1.40
Minimum data set for nutritional intervention studies in the elderly IAG/ IANA task force consensus. J Nutr Health Aging (2004) 1.40
[The role of CSF markers in the early diagnosis of Alzheimer's disease]. Tijdschr Psychiatr (2011) 1.39
The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme (1999) 1.36
Association between depressive symptoms and mortality in elderly people. Arch Intern Med (2001) 1.35
Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.34
Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study. Dement Geriatr Cogn Disord (2004) 1.34
The relation between global and limbic brain volumes on MRI and cognitive performance in healthy individuals across the age range. Neurobiol Aging (2000) 1.31
Contrasting results between caregiver's report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver's personal characteristics. J Am Geriatr Soc (1999) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology (1999) 1.30
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
Prospective study of restriction of activity in old people after falls. Age Ageing (1987) 1.28
IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging (2007) 1.28
Characterization of fibroblastic stromal cells from murine bone marrow. Exp Hematol (1985) 1.27
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry (2010) 1.24
Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol (1999) 1.24
Advances in the prevention of Alzheimer's disease and dementia. J Intern Med (2014) 1.23
Thalamic volume predicts performance on tests of cognitive speed and decreases in healthy aging. A magnetic resonance imaging-based volumetric analysis. Brain Res Cogn Brain Res (2001) 1.21
Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging (2012) 1.19
Development of a Salmonella-specific biotinylated DNA probe for rapid routine identification of Salmonella. Mol Cell Probes (1988) 1.19
[Immunoelectrophoretic study of the nature and the order of appearance of precipitating antibodies of rabbit serum as a function of their mode of immunization against Candica albicans]. Sabouraudia (1965) 1.18
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). Rheumatology (Oxford) (2004) 1.17
Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging (2010) 1.17
Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J Neurol (2007) 1.16
Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry (2000) 1.16
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry (2000) 1.16
The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia. Eur J Neurol (2005) 1.15
Realistic expectations for treatment success in Alzheimer's disease. J Nutr Health Aging (2006) 1.15
Myosin heavy chain expression in zebrafish and slow muscle composition. Dev Dyn (2005) 1.15
Management of osteoporosis in the elderly. Curr Med Res Opin (2009) 1.14
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study. Ann Oncol (2012) 1.14
Alzheimer disease: protective factors. Am J Clin Nutr (2000) 1.13
Implementing frailty into clinical practice: we cannot wait. J Nutr Health Aging (2012) 1.11
The New Mexico aging process study (1979-2003). A longitudinal study of nutrition, health and aging. J Nutr Health Aging (2007) 1.10